MedPath

Optiray

These highlights do not include all the information needed to use OPTIRAY safely and effectively. See full prescribing information for OPTIRAY.OPTIRAY (ioversol) injection, for intra-arterial or intra-venous useInitial U.S. Approval: 1988

Approved
Approval ID

549d38db-d4ed-4708-8f76-7cdaa157063f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 17, 2023

Manufacturers
FDA

Liebel-Flarsheim Company LLC

DUNS: 057880002

Products 3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ioversol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0019-1332
Application NumberNDA019710
Product Classification
M
Marketing Category
C73594
G
Generic Name
Ioversol
Product Specifications
Route of AdministrationINTRA-ARTERIAL, INTRAVENOUS
Effective DateFebruary 5, 2023
FDA Product Classification

INGREDIENTS (3)

TROMETHAMINEInactive
Code: 023C2WHX2V
Classification: IACT
EDETATE CALCIUM DISODIUMInactive
Code: 25IH6R4SGF
Classification: IACT
IOVERSOLActive
Quantity: 636 mg in 1 mL
Code: N3RIB7X24K
Classification: ACTIB

Ioversol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0019-1333
Application NumberNDA019710
Product Classification
M
Marketing Category
C73594
G
Generic Name
Ioversol
Product Specifications
Route of AdministrationINTRA-ARTERIAL, INTRAVENOUS
Effective DateFebruary 5, 2023
FDA Product Classification

INGREDIENTS (5)

IOVERSOLActive
Quantity: 741 mg in 1 mL
Code: N3RIB7X24K
Classification: ACTIB
TROMETHAMINEInactive
Quantity: 3.6 mg in 1 mL
Code: 023C2WHX2V
Classification: IACT
EDETATE CALCIUM DISODIUMInactive
Quantity: 0.2 mg in 1 mL
Code: 25IH6R4SGF
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

Ioversol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0019-1323
Application NumberNDA019710
Product Classification
M
Marketing Category
C73594
G
Generic Name
Ioversol
Product Specifications
Route of AdministrationINTRA-ARTERIAL, INTRAVENOUS
Effective DateFebruary 5, 2023
FDA Product Classification

INGREDIENTS (5)

EDETATE CALCIUM DISODIUMInactive
Quantity: 0.2 mg in 1 mL
Code: 25IH6R4SGF
Classification: IACT
TROMETHAMINEInactive
Quantity: 3.6 mg in 1 mL
Code: 023C2WHX2V
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
IOVERSOLActive
Quantity: 678 mg in 1 mL
Code: N3RIB7X24K
Classification: ACTIB
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Optiray - FDA Drug Approval Details